Collectively, our findings suggest that FOXD1 plays a critical role in establishing an aggressive phenotype in a basal-like breast cancer subset by maintaining tumor-promoting epigenetic features and gene expression patterns. This evidence concerns the gene FOXD1 and breast carcinoma.